35 studies found for:    mononucleosis
Show Display Options
Rank Status Study
1 Completed Acupuncture for Infectious Mononucleosis Trial
Condition: Infectious Mononucleosis
Interventions: Procedure: traditional Chinese acupuncture;   Other: standard medical care
2 Completed Activity of Valomaciclovir in Infectious Mononucleosis Due to Primary Epstein-Barr Virus Infection
Condition: Infectious Mononucleosis
Interventions: Drug: Valomaciclovir;   Drug: placebo
3 Completed Controlled Trial of Valacyclovir in Infectious Mononucleosis
Condition: Infectious Mononucleosis
Intervention: Drug: valacyclovir
4 Completed Evaluation of Safety, Immune-Response and Efficacy of GSK Biologicals’ EBV (Epstein Barr Virus) Vaccine (268664).
Condition: Epstein Barr Virus (EBV) Infection
Intervention: Biological: EBV vaccine (268664)
5 Recruiting Genetic Studies of Chronic Active Epstein-Barr Disease
Condition: Epstein-Barr Virus Infections
Intervention:
6 Completed Genetic Studies of X-linked Lymphoproliferative Disease
Conditions: X-Linked Lymphoproliferative Disease;   Lymphoproliferative Disease;   Genetic Diseases, X-Linked
Intervention:
7 Recruiting A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Conditions: Congenital Cytomegalovirus Infection;   Maternal Cytomegalovirus Infection
Intervention: Drug: CMV hyperimmune globulin
8 Completed Prospective Study of Possible Infectious Disease - Associated Antigen Drive in Previously Untreated Indolent Lymphoma
Condition: Indolent Non-Hodgkin's Lymphoma
Intervention:
9 Not yet recruiting TGF-beta Resistant Cytotoxic T-lymphocytes in Treatment of EBV-positive Nasopharyngeal Carcinoma / RESIST-NPC
Condition: EBV-positive Nasopharyngeal Carcinoma
Intervention: Genetic: DNR.NPC-specific CTLs
10 Terminated Giving Gene Marked EBV Specific T-Cells to Patients Receiving a BMT for Relapsed EBV-Positive Hodgkin Disease
Conditions: Hodgkin Disease;   Non-Hodgkins Lymphoma
Intervention: Drug: Infusion of EBV Specific Cytotoxic T-Lymphocytes
11 Completed
Has Results
Accelerated Immunization to Induce Cytomegalovirus Immunity in Stem Cell Donors
Condition: Cytomegalovirus Infections
Intervention: Biological: ALVAC-CMV (vCP260)
12 Unknown  HIV Indicator Diseases Across Europe Study
Condition: HIV
Intervention:
13 Completed Epstein Barr Virus (EBV) Specific Cytotoxic T-Cells, Relapsed Lymphoma, ANGEL
Conditions: Epstein-Barr Virus-Related Hodgkin Lymphoma;   Epstein-Barr Virus-Related Non-Hodgkin Lymphoma;   EBV Positive Plasma Cell Neoplasm
Intervention: Genetic: Injection of EBV Specific CTLs
14 Recruiting Administration of TAA-Specific CTLs; Hodgkin or Non-Hodgkin Lymphoma; TACTAL
Conditions: Hodgkin Lymphoma;   Non-Hodgkin Lymphoma;   Hodgkin Disease
Interventions: Biological: Antigen Escalation Stage;   Biological: Dose escalation study of T cells
15 Completed T-Lymphocytes in Treating Patients With Epstein-Barr Virus-Positive Nasopharyngeal Cancer, NPC
Condition: Head and Neck Cancer
Intervention: Biological: autologous EBV specific CTLs
16 Recruiting Specific Cytotoxic T-Lymphocytes, EBV-positive Lymphoma, GRALE
Conditions: Hodgkin's Disease;   Non-Hodgkin's Lymphoma;   Lymphoproliferative Disease;   Lymphoma
Interventions: Biological: LMP, BARF1 & EBNA1 specific CTLs: A;   Biological: LMP, BARF1 & EBNA1 specific CTLs : B
17 Completed LMP1- and LMP2-Specific CTLs to Patients With EBV-Positive NPC (NATELLA)
Condition: Nasopharyngeal Carcinoma
Intervention: Genetic: Genetically modified CTLs
18 Terminated Lmp1 and Lmp2 Specific CTLs Following Cd45 Antibody for Relapsed Ebv-Positive Hodgkin's Or Non-Hodgkin's Lymphoma
Conditions: Hodgkins Lymphoma;   Non-Hodgkin Lymphoma
Interventions: Genetic: LMP1 SPECIFIC CYTOTOXIC T-LYMPHOCYTES;   Genetic: LMP2-SPECIFIC CYTOTOXIC T-LYMPHOCYTES
19 Terminated Vaccination With Tetanus and KLH to Assess Immune Responses.
Condition: Cancer
Interventions: Biological: Intracel KLH Vaccine;   Biological: Biosyn KLH;   Drug: Montanide ISA51;   Biological: Tetanus toxoid
20 Recruiting Most Closely HLA-Matched CTLs for Relapsed Epstein Barr Virus(EBV)-Associated Diseases
Conditions: Hodgkin Lymphoma;   Non-Hodgkin Lymphoma;   Lymphoproliferative Disorder;   Nasopharyngeal Carcinoma;   Leiomyosarcoma;   Severe Chronic Active EBV (SCAEBV)
Intervention: Biological: LMP specific T cells

   Previous Page Studies Shown (1-20) Next Page (21-35) Show next page of results    Last Page
Indicates status has not been verified in more than two years